“To deliver on the true promise of this technology to improve lives, you need to be able to access the entire surface of the brain without harming it. That’s what Layer 7 is designed to achieve.”
Mager is a business builder with experience leading technology and technology-enabled companies. He cofounded Precision Neuroscience and serves as its Chief Executive Officer. He previously co-founded Assembly Software, where he is Co-Chairman, and serves on the Board of Maimonides Hospital. Mager holds an MPhil in economic history from the University of Cambridge and an AB from Harvard College, and he is a CFA Charterholder.
Mermel is a pathologist and data scientist who has spent his career at the intersection of life sciences and artificial intelligence. At Precision, he oversees AI and data strategy, including development and use of the company’s neural dataset. He previously led AI-driven cancer research at Google and helped develop health and fitness features for the Apple Watch at Apple. Mermel holds an MD and PhD in genetics from Harvard University.
Rapoport is a neurosurgeon and electrical engineer widely regarded as a leading authority in brain–computer interface technology. He cofounded Precision Neuroscience, where he oversees the company’s scientific and clinical programs. Before founding Precision, he was a co-founder of Neuralink. He holds an MD from Harvard Medical School and a PhD in electrical engineering and computer science from MIT.
Kaswan is a healthcare executive with more than 30 years of experience as a CFO, CEO, and venture investor. He joined Precision as Chief Financial Officer after serving as CFO of Orchestra BioMed Holdings, which he helped take public in 2022. He holds an MBA from Harvard Business School.
Strauss is a healthcare executive with a track record of bringing innovation into clinical practice to improve patient outcomes. At Precision, she leads the company’s clinical strategy and partnerships. Previously, as Chief Clinical Officer at Viz.ai, she scaled adoption from a handful of hospitals to more than a thousand and built clinical evidence demonstrating AI’s impact on patient care. Strauss holds an MSN and MBA from Grand Canyon University and a BSN from Cedar Crest College.
Woock is a medtech executive with extensive experience building and implementing commercial strategies for medical device companies. At Precision, he oversees business strategy and commercialization. He previously served as Executive Vice President and Chief Marketing & Strategy Officer at Axonics, where he led the company’s 500-person commercial team prior to its $3.7 billion acquisition by Boston Scientific. Woock holds a PhD in biomedical engineering from Duke University and was a Stanford Biodesign Innovation Fellow.
Greengrass is a people and culture leader with more than three decades of experience shaping talent, culture, and organizational design across global companies. At Precision, he leads the People team and develops programs that support growth, innovation, and employee experience. Before joining Precision, he was Chief People Officer at Yieldstreet and held senior leadership roles at BuzzFeed, FanDuel, and Equinox Fitness. Greengrass holds an MBA from NYU Stern School of Business and is a certified professional coach.
Pletcher is an electrical engineer with two decades of experience leading the design and commercialization of advanced integrated circuits and systems across medical, wireless, and machine-learning applications. At Precision, he directs technology development and engineering. Before joining the company, he held senior hardware leadership roles at Google, Verily, and X (formerly Google X), where he focused on implantable and wearable medical devices. Pletcher earned his MS and PhD in electrical engineering from the University of California, Berkeley.
Tolosa is Senior Vice President of R&D Operations, where she leads Precision’s research and development operations with a focus on scaling technologies toward production manufacturing. She has more than 20 years of experience developing materials and hardware for biomedical implants. Before joining Precision, she led a hardware research team at Meta’s Reality Labs and was a member of the eight-person co-founding team at Neuralink. Tolosa holds a PhD in chemical engineering from UCLA.
Mager is a business builder with experience leading technology and technology-enabled companies. He cofounded Precision Neuroscience and serves as its Chief Executive Officer. He previously co-founded Assembly Software, where he is Co-Chairman, and serves on the Board of Maimonides Hospital. Mager holds an MPhil in economic history from the University of Cambridge and an AB from Harvard College, and he is a CFA Charterholder.
Mermel is a pathologist and data scientist who has spent his career at the intersection of life sciences and artificial intelligence. At Precision, he oversees AI and data strategy, including development and use of the company’s neural dataset. He previously led AI-driven cancer research at Google and helped develop health and fitness features for the Apple Watch at Apple. Mermel holds an MD and PhD in genetics from Harvard University.
Rapoport is a neurosurgeon and electrical engineer widely regarded as a leading authority in brain–computer interface technology. He cofounded Precision Neuroscience, where he oversees the company’s scientific and clinical programs. Before founding Precision, he was a co-founder of Neuralink. He holds an MD from Harvard Medical School and a PhD in electrical engineering and computer science from MIT.
Kaswan is a healthcare executive with more than 30 years of experience as a CFO, CEO, and venture investor. He joined Precision as Chief Financial Officer after serving as CFO of Orchestra BioMed Holdings, which he helped take public in 2022. He holds an MBA from Harvard Business School.
Strauss is a healthcare executive with a track record of bringing innovation into clinical practice to improve patient outcomes. At Precision, she leads the company’s clinical strategy and partnerships. Previously, as Chief Clinical Officer at Viz.ai, she scaled adoption from a handful of hospitals to more than a thousand and built clinical evidence demonstrating AI’s impact on patient care. Strauss holds an MSN and MBA from Grand Canyon University and a BSN from Cedar Crest College.
Woock is a medtech executive with extensive experience building and implementing commercial strategies for medical device companies. At Precision, he oversees business strategy and commercialization. He previously served as Executive Vice President and Chief Marketing & Strategy Officer at Axonics, where he led the company’s 500-person commercial team prior to its $3.7 billion acquisition by Boston Scientific. Woock holds a PhD in biomedical engineering from Duke University and was a Stanford Biodesign Innovation Fellow.
Greengrass is a people and culture leader with more than three decades of experience shaping talent, culture, and organizational design across global companies. At Precision, he leads the People team and develops programs that support growth, innovation, and employee experience. Before joining Precision, he was Chief People Officer at Yieldstreet and held senior leadership roles at BuzzFeed, FanDuel, and Equinox Fitness. Greengrass holds an MBA from NYU Stern School of Business and is a certified professional coach.
Pletcher is an electrical engineer with two decades of experience leading the design and commercialization of advanced integrated circuits and systems across medical, wireless, and machine-learning applications. At Precision, he directs technology development and engineering. Before joining the company, he held senior hardware leadership roles at Google, Verily, and X (formerly Google X), where he focused on implantable and wearable medical devices. Pletcher earned his MS and PhD in electrical engineering from the University of California, Berkeley.
Tolosa is Senior Vice President of R&D Operations, where she leads Precision’s research and development operations with a focus on scaling technologies toward production manufacturing. She has more than 20 years of experience developing materials and hardware for biomedical implants. Before joining Precision, she led a hardware research team at Meta’s Reality Labs and was a member of the eight-person co-founding team at Neuralink. Tolosa holds a PhD in chemical engineering from UCLA.
“I collaborate with and elevate the voices of our diverse users to ensure we build the right products, in the right way.”
“My drive comes from listening to clinicians—understanding what truly matters in their workflows so we can design a system they’ll actually adopt.”
“I’m working to make sure that all of our hardware systems—from implantable devices to surgical tools—perform reliably and intuitively.”
“My team pushes the boundaries of science to develop materials that safely live in the body long-term.
"The exciting part of my work and the challenge—is seeing brain activity at a level of detail no one's had access to before."
"I design and refine our visual identity, ensuring that our audiences enjoy a consistent, beautiful brand experience."
"In the OR and in the ICU, I work with clinicians and patients to collect data that advances our ability to decode thought."
"We are working at the intersection of neuroscience and Al to decode brain signals— developing algorithms that make BCIs more accurate and responsive for users."
